Early-stage lung adenocarcinomas are occasionally seen at late stages, following prolonged KrasG12D expression, and can be accelerated by a combined p53 (also known as Trp53) mutation (Jackson et al., 2005). The gene discussed is TP53; the disease is lung adenocarcinoma.